alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                            DEC-31-1996                    
<PERIOD-END>                                 SEP-30-1996
<CASH>                                            25,098
<SECURITIES>                                           0
<RECEIVABLES>                                          0
<ALLOWANCES>                                           0
<INVENTORY>                                       35,515
<CURRENT-ASSETS>                                  94,268
<PP&E>                                           310,080
<DEPRECIATION>                                   104,818
<TOTAL-ASSETS>                                   323,606
<CURRENT-LIABILITIES>                             72,242
<BONDS>                                          106,837
<COMMON>                                               0
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                            0
<OTHER-SE>                                             0
<TOTAL-LIABILITY-AND-EQUITY>                     323,606
<SALES>                                          375,775
<TOTAL-REVENUES>                                 375,775
<CGS>                                            267,245
<TOTAL-COSTS>                                    327,552
<OTHER-EXPENSES>                                       0
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                                     0
<INCOME-PRETAX>                                   26,723
<INCOME-TAX>                                      10,422
<INCOME-CONTINUING>                               16,301
<DISCONTINUED>                                       (13)
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                      16,288
<EPS-PRIMARY>                                       1.45
<EPS-DILUTED>                                          0
        

</TABLE>
## R.EOEtVEI

· &PPT 

# erne**201~-HAY** 

## -2 At111: 

## 42

April17, 2014

Director, Chemical Control Division

US Environmental Protection Agency

Office of Pollution Prevention and Toxics

EPA East

Room4146

1201 Constitution Avenue, NW

Washington, DC 20004



### Re: EPA- HQ

- OPPT- 2003

- 0012 CBIC Control Number 

# 359833

DuPont Chemicals and Fluoroproducts

Chambers Works

Deepwater, NJ 08023



### DuPont Chambers Works NJPDES Permit No. NJ0005100

PFOA Data Submittal- Outfall DSN662 Weekly Grab Samples

March 2014 Sample Data

Dear Chemical Control Division:

Attached please find summaries of PFOA analytical results for the DuPont Chambers Works

weekly grab samples taken at internal outfall DSN662A in March 2014. In accordance with the

current site NJPDES permit (NJ00051 00, effective September 2011 ), these resuits are provided

to NJDEP on a monthly basis via electronic discharge monitoring reports. The enclosures

include two paper and two electronic copies of the analytical results from this monitoring period.

Sincerely,

# ~ Albert Patrick O'Neill

Unit Manager-Site Manufacturing Systems/Fluoroproducts

DuPont Chambers Works

APO/clc

Enclosures**--------------------------------·---------------~---------------------------------**Copy to:

Document Control Office

US Environmental Protection Agency

Office of Pollution Prevention and Toxics

EPA East

Room6428

1200 Pennsylvania Avenue, NW

Washington, DC 20460

Ms. Susan Rosenwinkel (cover letter only)

Principal Environmental Engineer

NJDEP Division of Water Quality

Bureau of Water Surfacing

Mail Code 40 1-02B

401 

### E. State Street

P.O. Box420

Trenton, NJ 08625-0420

,: ·• !ISampleIDDateTop(ft)Total(T)/Bottom(ft)AnalyteunitsDiss.(D)Duplicate#PFOAug/LTSummaryofAnalyticalResults662-March2014662-GRAB662-GRAB662-GRAB662-GRAB3/3/143/10/143/17/143/24/140000000011112.572.314.303.05PFOA=PerfluorooctanoicAcidug/L=microgramsperLiterug/L=microgramsperliterorpartsperbillion(ppb)LOQ=limitofquantification=0.100ug/L662-GRAB3/31/140013.49SampleswereanalyzedbyCriticalPathServicesLLC.Reportedresultsrepresentasingleanalysis,exceptforthesamplecollectedon3/24/14.Acceptableprecisionwasobtainedandthereportedresultforthesamplecollectedon3/24/14representstheaverageoflabduplicateresults.TheNJDEPlabcertificationnumberforCriticalPathServicesLLCisPA072.<andND=NondetectatstatedreportinglimitPage1of1Copyofcwk662grabresults_mar14.xls:Sheet14/29/20148:58AM
[Federal Register Volume 74, Number 146 (Friday, July 31, 2009)]
[Notices]
[Pages 38192-38193]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-18290]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institute for Occupational Safety and Health; Final 
Effect of Designation of a Class of Employees for Addition to the 
Special Exposure Cohort

AGENCY: National Institute for Occupational Safety and Health, 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: HHS gives notice concerning the final effect of the HHS 
decision to designate a class of employees at Area IV of the Santa 
Susana Field Laboratory, as an addition to the Special Exposure Cohort 
(SEC) under the Energy Employees Occupational Illness Compensation 
Program Act of 2000. On June 18, 2009, as provided for under 42 U.S.C. 
7384q(b), the Secretary of HHS designated the following class of 
employees as an addition to the SEC:

All employees of the Department of Energy (DOE), its predecessor 
agencies, and DOE contractors and subcontractors who worked in any 
area of Area IV of the Santa Susana Field Laboratory for a number of 
work days aggregating at least 250 work days from January 1, 1955 
through December 31, 1958, or in combination with work days within 
the parameters established for one or more other classes of 
employees in the SEC.

    This designation became effective on July 18, 2009, as provided for 
under 42 U.S.C. 7384l(14)(C). Hence, beginning on July 18, 2009, 
members of this class of employees, defined as reported in this notice, 
became members of the Special Exposure Cohort.

FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of 
Compensation Analysis and Support, National Institute for Occupational 
Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, Cincinnati, 
OH 45226, Telephone 513-533-6800 (this is not a toll-free number). 
Information requests can also

[[Page 38193]]

be submitted by e-mail to <a href="/cdn-cgi/l/email-protection#47080406140704030469000811"><span class="__cf_email__" data-cfemail="39767a786a797a7d7a177e766f">[email protected]</span></a>.

Christine M. Branche,
Acting Director, National Institute for Occupational Safety and Health.
[FR Doc. E9-18290 Filed 7-30-09; 8:45 am]
BILLING CODE 4163-19-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
exv10w22



 





Exhibit 10.22




Director Compensation Summary




     Each director of our general partner who is not an employee of our general partner is
reimbursed for any travel, lodging and other out-of-pocket expenses related to meeting attendance
or otherwise related to service on the board (including, without limitation, reimbursement for
continuing education expenses). Each non-employee director is currently paid an annual retainer fee of $45,000. Mr.
Armstrong is otherwise compensated for his services as an employee and therefore receives no
separate compensation for his services as a director. In addition to the annual retainer, each
committee chairman (other than the chairman of the audit committee) receives $2,000 annually. The
chairman of the audit committee receives $30,000 annually, and the other members of the audit
committee receive $15,000 annually, in each case, in addition to the annual retainer. Mr. Petersen
assigns any compensation he receives in his capacity as a director to EnCap Energy Capital Fund
III, L.P. (EnCap III), which is controlled by EnCap Investments L.P., of which Mr. Petersen is a
Managing Director. Mr. Capobianco assigns any compensation he receives in his capacity as a
director to Vulcan Capital.



     Our non-employee directors receive LTIP awards or cash equivalent awards as part of their
compensation. The LTIP awards vest annually in 25% increments and have an automatic re-grant feature
such that as they vest, an equivalent amount is granted. The three non-employee directors who
serve on our audit committee each received a grant of 10,000 units (vesting 2,500 units per year),
and Mr. Sinnott received a grant of 5,000 units (vesting 1,250 units per year). For Mr. Petersen
and Mr. Capobianco, a cash payment equivalent in value to the annual vesting of Mr. Sinnott’s award
will be made to EnCap III and Vulcan Capital, respectively. All LTIP awards held by a director
will vest in full upon the next vesting date after the death or disability (as determined in good
faith by the board) of the director. For any “independent” directors (as defined in the GP LLC
Agreement, and currently including Messrs. Goyanes, Smith and Symonds), the units will also vest in
full if such director (i) retires (no longer with full-time employment and no longer serving as an
officer or director of any public company) or (ii) is removed from the Board or is not reelected to
the Board, unless such removal or failure to reelect is for “good cause,” as defined in the letter
granting the phantom units.
§ 876.5011 Metallic biliary stent system for benign strictures. ( a ) *Identification.* A metallic biliary stent system for benign strictures is a prescription device intended for the treatment of benign biliary strictures. The biliary stents are intended to be left indwelling for a limited amount of time and subsequently removed. The device consists of a metallic stent and a delivery system intended to place the biliary stent in the bile duct. This device type is not intended for use in the vasculature.
( b ) *Classification.* Class II (special controls). The special controls for this device are: ( 1 ) Clinical performance testing must demonstrate or provide the following: ( i ) The ability to safely place and subsequently remove the stent after the maximum labeled indwell period.
( ii ) All adverse event data including bile duct obstruction and trauma to the bile duct.
( iii ) The stent resolves strictures during the maximum labeled indwell period.
( iv ) Stricture resolution is maintained post-stent removal.
( 2 ) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be demonstrated: ( i ) Corrosion testing to demonstrate that the stent maintains its integrity during indwell and does not release potentially toxic levels of leachables.
( ii ) Stent dimensional testing supports the intended use.
( iii ) Compression and expansion forces must be characterized.
( iv ) The delivery catheter must deliver the stent to the intended location and the stent must not be adversely impacted by the delivery catheter during deployment and catheter withdrawal.
( v ) The delivery system must withstand clinically anticipated forces.
( vi ) Compatibility in a magnetic resonance environment.
( 3 ) All patient contacting components of the device must be demonstrated to be biocompatible.
( 4 ) Performance data must demonstrate the sterility of the device components intended to be provided sterile.
( 5 ) Shelf life testing must demonstrate that the device maintains its performance characteristics and that packaging maintains sterility for the duration of the labeled shelf life.
( 6 ) Labeling for the device must include: ( i ) A detailed summary of the clinical testing including device effectiveness, and device- and procedure-related adverse events.
( ii ) Appropriate warning(s) to accurately ensure usage of the device for the intended patient population.
( iii ) Shelf life.
( iv ) Compatibility information for use in the magnetic resonance environment.
( v ) Stent foreshortening information supported by dimensional testing.
[81 FR 45231, July 13, 2016]
EXHIBIT 32.2

                         CERTIFICATION PURSUANT TO
                          18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO SECTION 906
                     OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Quarterly Report of Giant Industries, Inc.
("Giant") on Form 10-Q for the quarter ending March 31, 2005, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Mark B. Cox, Chief Financial Officer of Giant, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

     (a)  The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (b)  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of
Giant.


                                       By: /s/ MARK B. COX
                                         -------------------------------
                                       Name:   Mark B. Cox
                                       Title:  Chief Financial Officer

Date: May 6, 2005
H. Con. Res. 221 Agreed to September 28, 1996

One Hundred Fourth Congress

of the

United States of America

AT THE SECOND SESSION

Begun and held at the City of Washington on Wednesday,

the third day of January, one thousand nine hundred and ninety-six

Concurrent Resolution

Correcting the enrollment of H.R. 3159.

Resolved by the House of Representatives (the Senate concurring), That, in the enrollment of the bill H.R. 3159, the Clerk

of the House of Representatives shall make the following corrections:

(1) In section 5902(b) proposed to be inserted in title 49,

United States Code, by section 204(b), strike ‘‘electric’’ and

insert ‘‘electronic’’.

(2) In section 204(e)(1), by inserting after ‘‘respectively’’

the following: ‘‘, and by moving the text of paragraph (2),

as so redesignated down 1 line and to the left, flush full

measure and indenting such paragraph’’.

(3) In section 205(1), by inserting ‘‘in subsection (a)’’ before

‘‘a comma’’.

(4) In paragraph (4) of section 5905(a) proposed to be

inserted in title 49, United States Code, by section 206, after

‘‘(c),’’, move the remainder of the text of the paragraph down

1 line and to the left, flush full measure.

(5) In section 206(2), by striking ‘‘9(b)(1)’’ and inserting

‘‘(b)(1)’’.

Attest:

Clerk of the House of Representatives.

Attest:

Secretary of the Senate.
exv10wxay



 





Exhibit 10(a)




Amendment to Long-Term Incentive Compensation Plan




     Effective February 28, 2007, Section 2.1(l) of the Long-Term Incentive Compensation Plan was
amended in its entirety to read as follows:




	 	(l)	 	“Fair Market Value” as of any date means, unless a different
calculation measure is specified by the Committee, that day’s closing sales price
of a Share on the New York Stock Exchange.




Action of Human Resources Committee Specifying “Fair Market Value” for February 27, 2007 Option
Grants Under the Long-Term Incentive Compensation Plan and for Option Exercises Involving a Market
Transaction




     RESOLVED that for purposes of the option grants under the Plan approved by the Committee on
February 27, 2007, “Fair Market Value” shall mean the closing sales price of a Share on the New
York Stock Exchange for February 27, 2007.



     RESOLVED that for purposes of determining the amount of compensation and withholding taxes
from a cashless exercise (same-day sale) or other Option exercise involving a market transaction,
“Fair Market Value” shall mean the actual price at which the sale transaction occurs.
Michigan Supreme Court

Lansing, Michigan

Bridget M. McCormack

, Chief Justice

David F. Viviano,

Chief Justice Pro Tem

Stephen J. Markman

Brian K. Zahra

Richard H. Bernstein

Elizabeth T. Clement

Megan K. Cavanagh,

Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

April 22, 2020

b0415 

# Order

Clerk April 22, 2020

160767 & (59)(60)

In re EMONI DOMINIQUE LIPSCOMB SC: 160767

COA: 351259

Oakland CC Family Div:

2019

- 874296

- DL

_________________________________________/

On order of the Court, the motion for immediate consideration is GRANTED. The

application for leave to appeal the December 12, 2019 order of the Court of Appeals is

c onsidered, and it is DENIED, because we are not persuaded that the questions presented

should be reviewed by this Court. The motion for miscellaneous relief is DENIED.
| (logo) WELLS FARGO | **Commercial Mortgage  Servicing**D1050-084, 8th Floor  401 South Tryon St.  Charlotte, NC 28202  1-800-326-1334 |
|--------------------|------------------------------------------------------------------------------------------------------------------|

 

 

**ANNUAL STATEMENT OFCOMPLIANCE**

 

Reference is hereby made tothat certain Pooling and Servicing Agreement dated as of September 1, 2015, byand among WELLS FARGO COMMERCIAL MORTGAGE SECURITIES, INC., as Depositor, WELLSFARGO BANK, NATIONAL ASSOCIATION, as General Master Servicer, RIALTO CAPITALADVISORS, LLC, as General Special Servicer, NATIONAL COOPERATIVE BANK, N.A., asNCB Master Servicer, NATIONAL COOPERATIVE BANK,    N.A., as NCBSpecial Servicer, PARK BRIDGE LENDER SERVICES LLC, as Trust Advisor, WELLSFARGO BANK, NATIONAL ASSOCIATION, as Certificate Administrator, as TaxAdministrator and as Custodian and WILMINGTON TRUST, NATIONAL ASSOCIATION, asTrustee, with respect to Commercial Mortgage Pass-Through Certificates Series2015-LC22 (the "Agreement"). Capitalized terms used herein nototherwise defined shall have the meanings assigned in the Agreement.

 

Pursuant to Section 11.12 of thisAgreement, I, Daniel Bober, Executive Vice President of Commercial MortgageServices do hereby certify that:

 

1. A review of the activitiesof the General Master Servicer during the period from January 1, 2016 throughDecember 31, 2016 (the “Reporting Period”) , and of its performanceper the Agreement during such period has been made under my supervision, and

 

2. To the best of myknowledge, based on such review, the General Master Servicer, has fulfilled allof its obligations under this Agreement in all material respects throughout the Reporting Period.

 

 

IN WITNESS WHEREOF, theundersigned has executed this Certificate as of the 28th day of February 2017.

 

 

/s/ Daniel Bober 

Daniel Bober

Executive Vice President 

Wells Fargo Bank

 

 

| Wells Fargo Bank, N.A. | (logo) Together we’ll  go far |
|------------------------|-------------------------------------|
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                         231,485
<SECURITIES>                                         0
<RECEIVABLES>                                1,551,490
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,901,008
<PP&E>                                          90,303
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  90,303
<CURRENT-LIABILITIES>                        1,828,734
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      5,100
<COMMON>                                        13,684
<OTHER-SE>                                   3,458,573
<TOTAL-LIABILITY-AND-EQUITY>                 5,306,271
<SALES>                                        120,251
<TOTAL-REVENUES>                               120,251
<CGS>                                            3,008
<TOTAL-COSTS>                                  896,307
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                798,557
<INCOME-TAX>                                    14,744
<INCOME-CONTINUING>                            813,301
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (919,551)
<EPS-BASIC>                                     (.067)
<EPS-DILUTED>                                   (.067)


</TABLE>
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 98-1799
DOYAL FINLEY, Plaintiff - Appellant, versus FEDERAL EXPRESS CORPORATION, Defendant - Appellee. Appeal from the United States District Court for the District of Maryland, at Greenbelt. Alexander Williams, Jr., District Judge. (CA-97-622-AW) Submitted: July 30, 1998 Decided: August 26, 1998 Before WIDENER, LUTTIG, and WILLIAMS, Circuit Judges. Affirmed by unpublished per curiam opinion.Doyal Finley, Appellant Pro Se. Eric Hemmendinger, SHAWE & ROSENTHAL, Baltimore, Maryland; Colby S. Morgan, Jr., FEDERAL EXPRESS CORPORATION, Memphis, Tennessee, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM:Appellant appeals the district court’s order granting Defendant’s summary judgment. We have reviewed the record and the district court’s opinion and find no reversible error. Accordingly, we affirm on the reasoning of the district court. Finley v. Federal Express Corp. , No. CA-97-622-AW (D. Md. Feb. 28, 1997). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
<PAGE>   1

                                   EXHIBIT 4.3


January 19, 1999


Rick Smyth
Lahaina Acquisitions, Inc.
2900 Atlantic Avenue
Fernandina Beach, FL 32034

Dear Rick:

This letter agreement will confirm the amendments in the 9% Convertible Note as
follows:

         2.       Amend the conversion price on the second $375,000 from 85% of
                  the 5 day Weighted Average Sale Price to a conversion price of
                  $875.

These amendments do not change any other terms of the agreement, rights of GCA
Strategic Investment Funds, Ltd., or obligations of Lahaina Acquisitions, Inc.,
under the agreement.



-----------------------------------
GCA Strategic Investment Fund, Ltd.



-----------------------------------
Rick Smyth
Lahaina Acquisitions, Inc.




                                      E-1